Gowtham A Rao
Overview
Explore the profile of Gowtham A Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rao G, Shoaibi A, Makadia R, Hardin J, Swerdel J, Weaver J, et al.
PLoS One
. 2025 Jan;
20(1):e0310634.
PMID: 39820599
Objective: This paper introduces a novel framework for evaluating phenotype algorithms (PAs) using the open-source tool, Cohort Diagnostics. Materials And Methods: The method is based on several diagnostic criteria to...
2.
Schuemie M, Reps J, Black A, DeFalco F, Evans L, Fridgeirsson E, et al.
Stud Health Technol Inform
. 2024 Jan;
310:966-970.
PMID: 38269952
The Health-Analytics Data to Evidence Suite (HADES) is an open-source software collection developed by Observational Health Data Sciences and Informatics (OHDSI). It executes directly against healthcare data such as electronic...
3.
Makadia R, Shoaibi A, Rao G, Ostropolets A, Rijnbeek P, Voss E, et al.
JAMIA Open
. 2023 Nov;
6(4):ooad096.
PMID: 38028730
Objective: Developing accurate phenotype definitions is critical in obtaining reliable and reproducible background rates in safety research. This study aims to illustrate the differences in background incidence rates by comparing...
4.
Shoaibi A, Rao G, Voss E, Ostropolets A, Mayer M, Ramirez-Anguita J, et al.
Drug Saf
. 2022 Jun;
45(6):685-698.
PMID: 35653017
Introduction: Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) vaccines. Objectives: In this study, we explored the pre-pandemic...
5.
Lane J, Weaver J, Kostka K, Duarte-Salles T, Abrahao M, Alghoul H, et al.
Rheumatology (Oxford)
. 2020 Dec;
60(7):3222-3234.
PMID: 33367863
Objectives: Concern has been raised in the rheumatology community regarding recent regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute psychiatric events. We aimed to...
6.
Lane J, Weaver J, Kostka K, Duarte-Salles T, Abrahao M, Alghoul H, et al.
Lancet Rheumatol
. 2020 Sep;
2(11):e698-e711.
PMID: 32864627
Background: Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients...
7.
Burn E, Chan You S, Sena A, Kostka K, Abedtash H, Abrahao M, et al.
medRxiv
. 2020 Jun;
PMID: 32511443
Background In this study we phenotyped individuals hospitalised with coronavirus disease 2019 (COVID-19) in depth, summarising entire medical histories, including medications, as captured in routinely collected data drawn from databases...
8.
Wang Q, Reps J, Kostka K, Ryan P, Zou Y, Voss E, et al.
PLoS One
. 2020 Jan;
15(1):e0226718.
PMID: 31910437
Background And Purpose: Hemorrhagic transformation (HT) after cerebral infarction is a complex and multifactorial phenomenon in the acute stage of ischemic stroke, and often results in a poor prognosis. Thus,...
9.
Shoaibi A, Rao G, Cai B, Rawl J, Haddock K, Hebert J
Prostate
. 2016 Oct;
77(2):173-184.
PMID: 27699819
Purpose: To investigate if a prostate specific antigen (PSA)-derived growth curve can predict the occurrence of high-risk prostate cancer (PrCA). Methods: Data from 38,340 men randomized to the PrCA screening...
10.
Shoaibi A, Rao G, Cai B, Rawl J, Hebert J
Ann Epidemiol
. 2015 Nov;
26(1):36-42.e1-2.
PMID: 26611771
Purpose: To test the hypothesis that the pattern of prostate-specific antigen (PSA) change in men diagnosed with high-risk prostate cancer (PrCA) differs from the pattern evident in men diagnosed with...